{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:01:43Z","timestamp":1790870503095,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clnu.2026.106680","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:23:16Z","timestamp":1778552596000},"page":"106680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characteristics and clinical applicability of four dietary interventions for irritable bowel syndrome: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3204-9414","authenticated-orcid":false,"given":"Xinpeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindong","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clnu.2026.106680_bib1","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ajcn\/nqab005","volume":"113","author":"Zhang","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2026.106680_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/ajcn\/nqab337","article-title":"Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial","volume":"115","author":"Nordin","year":"2022","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10.1016\/j.clnu.2026.106680_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.70060","article-title":"Efficacy of Mediterranean Diet vs. Low-FODMAP Diet in Patients With Nonconstipated Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial","volume":"37","author":"Singh","year":"2025","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"10.1016\/j.clnu.2026.106680_bib4","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.cgh.2022.02.045","article-title":"Efficacy and acceptability of dietary therapies in non-constipated irritable bowel syndrome: A randomized trial of traditional dietary advice, the low FODMAP diet, and the gluten-free diet","volume":"20","author":"Rej","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2026.106680_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: Management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clnu.2026.106680_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11306-023-02083-x","article-title":"Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome-a double-blind randomized cross-over challenge study","volume":"20","author":"Nordin","year":"2024","journal-title":"Metabolomics"},{"issue":"12","key":"10.1016\/j.clnu.2026.106680_bib7","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.clnu.2022.11.001","article-title":"Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial","volume":"41","author":"Algera","year":"2022","journal-title":"Clin Nutr"},{"issue":"7","key":"10.1016\/j.clnu.2026.106680_bib8","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/nu11071662","article-title":"A dietary intervention with reduction of starch and sucrose leads to reduced gastrointestinal and extra-intestinal symptoms in IBS patients","volume":"11","author":"Nilholm","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2026.106680_bib9","article-title":"The Mediterranean diet for irritable bowel syndrome: A randomized clinical trial","volume":"28","author":"Bamidele","year":"2025","journal-title":"Ann Intern Med. Published online October"},{"issue":"17","key":"10.1016\/j.clnu.2026.106680_bib10","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3390\/nu16173039","article-title":"A starch- and sucrose-reduced diet has similar efficiency as low FODMAP in IBS-a randomized non-inferiority study","volume":"16","author":"Roth","year":"2024","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.clnu.2026.106680_bib11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/apt.17239","article-title":"Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome","volume":"56","author":"Algera","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.clnu.2026.106680_bib12","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.3390\/nu15133045","article-title":"Effects of FODMAPs and gluten on gut microbiota and their association with the metabolome in irritable bowel syndrome: a double-blind, randomized, crossover intervention study","volume":"15","author":"Nordin","year":"2023","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.clnu.2026.106680_bib17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3390\/nu17091545","article-title":"Clinical trial: A Mediterranean low-FODMAP diet alleviates symptoms of non-constipation IBS-randomized controlled study and volatomics analysis","volume":"17","author":"Kasti","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2026.106680_bib13","doi-asserted-by":"crossref","first-page":"683191","DOI":"10.3389\/fnut.2021.683191","article-title":"A low-FODMAP diet improves the global symptoms and bowel habits of adult IBS patients: A systematic review and meta-analysis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Nutr"},{"issue":"24","key":"10.1016\/j.clnu.2026.106680_bib14","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.3390\/jcm13247531","article-title":"Efficacy of dietary interventions for irritable bowel syndrome: A systematic review and network meta-analysis","volume":"13","author":"Haghbin","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.clnu.2026.106680_bib15","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.clnu.2026.106680_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.clnu.2026.106680_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ueg2.12227","article-title":"A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels","volume":"10","author":"Nilholm","year":"2022","journal-title":"United European Gastroenterol J"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S026156142600107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S026156142600107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:40:59Z","timestamp":1790869259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S026156142600107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"alternative-id":["S026156142600107X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106680","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and clinical applicability of four dietary interventions for irritable bowel syndrome: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106680"}}